Specific nonpeptide photoprobes as tools for the structural study of the angiotensin II AT1 receptor

Journal of Medicinal Chemistry

Volumn 42, Issue 22, 1999, Pages 4572-4583

  Nouet, Sandrine ^c   Dodey, Pierre R ^a   Bondoux, Michel R ^a   Pruneau, Didier ^a   Luccarini, Jean Michel ^a   Groblewski, Thierry ^c   Larguier, Renée ^c   Lombard, Colette ^c   Marie, Jacky ^c   Renaut, Patrice P ^a   Leclerc, Gérard ^b   Bonnafous, Jean Claude ^c  

^a Laboratoires Fournier SA   (France)

^b UNIV GRENOBLE ALPES   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 BUTYL 1 [(4 CARBOXYPHENYL)METHYL] 4 TERT BUTYL 1H IMIDAZOL 5 YL]METHYL TERT BUTYL]AMINO] 4 AZIDOBENZOIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PHOTOAFFINITY LABELING; RECEPTOR AFFINITY; RECEPTOR BLOCKING;

ANGIOTENSIN II; ANIMALS; AORTA; AZIDES; BENZOIC ACIDS; CHO CELLS; CRICETINAE; LIGANDS; LIVER; MUSCLE, SMOOTH, VASCULAR; MUTATION; PHOTOAFFINITY LABELS; RABBITS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; TRITIUM;

EID: 0033523955     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm991050l     Document Type: Article

References (54)

1. (a) Freidinger, R. Toward peptide receptor ligand drugs: progress on nonpeptides. In Progress in Drug Research; Jucker, E., Ed.; Birkhauser Verlag: Basel, 1993; pp 33-98.
2. (b) Timmermans, R. N. W. M.; Wong, P. C.; Chiu, A. T.; Herblin, W. F.; Benfield, P.; Carini, D. J.; Lee, R. J.; Wexler, R. R.; Saye, J. A. M.; Smith, R. D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 1993, 45, 205-251.
3. Lefkowitz, R. J.; Cotecchia, S.; Samama, P.; Costa, T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 1993, 14, 303-307.
4. Kenakin, T. Pharmacological Proteus? Trends Pharmacol. Sci. 1995, 16, 256-258.
5. Kenakin, T. Differences between natural and recombinant G protein-coupled receptor with varying receptor/G protein stoechiometry. Trends Pharmacol. Sci. 1997, 18, 456-464.
6. Hjorth, S. A.; Thirstrup, K.; Schwartz, T. W. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the k-opioid receptor. Mol. Pharmacol. 1996, 50, 977-984.
7. 2-adrenergic receptor. Biochemistry 1988, 27, 1813-1817.
8. Dennis, M.; Giraudat, J.; Kotzyba-Hibert, F.; Goeldner, M.; Hirth, C.; Chang, J. Y.; Lazure, C.; Chretien, M.; Changeux, J. P. Amino acids of the Torpedo Marmorata acetylcholine receptor a subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistry 1988, 27, 2346-2357.
9. Kurtenbach, E.; Curkis, C. A. M.; Padder, E. K.; Aitken, A.; Harris, A. C. M.; Hidine, E. C. Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfate bond formation. J. Biol. Chem. 1990, 265, 13702-13708.
10. 2 vasopressin receptor. Biochemistry 1993, 32, 13537-13544.
11. Adams, A. E.; Pines, M.; Nakamoto, C.; Behar, V.; Yang, Q. M.; Bessale, R.; Chorev, M.; Rosenblatt, M.; Levine, M. A.; Suva, L. J. Probing the bimolecular interactions of parathyroid hormone/ parathyroid hormone protein receptor. 2. Cloning, characterization and photoaffinity labeling of the recombinant human receptor. Biochemistry 1995, 34, 10553-10559.
12. Girault, S.; Sagan, S.; Bolbach, G.; Lavielle, S.; Chassaing, G. The use of photolabeled peptides to localize the substance-P binding site in the human neurokinin-1 tachykinin receptor. Eur. J. Biochem. 1996, 240, 215-222.
13. Phalipou, S.; Cotte, N.; Carnazzi, E.; Seyer, R.; Mahe, E.; Jard, S.; Barberis, C.; Mouillac, B. Mapping peptide-binding domains of the human VIA vasopressin receptor with a photoactivable linear peptide antagonist. J. Biol. Chem. 1997, 272, 23536-23544.
14. Poirot, S. S.; Escrieut, C.; Dufresne, M.; Martinez, J.; Bouisson, M.; Vaysse, N.; Fourmy, D. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Mol. Pharmacol. 1994, 45, 599-607.
15. 2 receptor with photolabile angiotensin analogues. J. Biol. Chem. 1997, 272, 8653-8659.
16. Escher, E. H. F.; Nguyen, T. M. D.; Robert, M.; Saint-Pierre, A.; Regoli, D. C. Photoaffinity labeling of the angiotensin II receptor. 1-Synthesis and biological activities of the labeling peptides. J. Med. Chem. 1978, 21, 860-864.
17. Marie, J.; Seyer, R.; Lombard, C.; Desarnaud, F.; Aumelas, A.; Jard, S.; Bonnafous, J. C. Affinity chromatography purification of angiotensin II receptor using photoactivable biotinylated probes. Biochemistry 1990, 29, 8943-8950.
18. Desarnaud, F.; Marie, J.; Lombard, C.; Larguier, R.; Lorca, T.; Jard, S.; Bonnafous, J. C. Deglycosylation and fragmentation of purified rat liver angiotensin II receptor. Application to the mapping of hormone binding domains. Biochem. J. 1993, 285, 289-297.
19. Keenan, R. M.; Weinstock, J.; Finkelstein, J. A.; Franz, R. G.; Gaitanopoulos, D. E.; Girard, G. R.; Hill, D. T.; Morgan, T. M.; Samanen, J. M.; Hempel, J.; Eggleston, D. S.; Aiyar, N.; Griffin, E.; Ohlstein, E. H.; Stack, E. J.; Weidley, E. F.; Edwards, R. Imidazole-5-acrylic acids: potent non peptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model. J. Med. Chem. 1992, 35, 3858-3872.
20. 3H] LF 7-0156, a new non peptide antagonist radioligand for the type 1 angiotensin II receptor. Mol. Pharmacol. 1994, 46, 693-701.
21. Dodey, P.; Bondoux, M.; Renaut, P.; Pruneau, D. 5-phenylaminomethylimidazole derivatives: process of their preparation, angiotensin II receptor antagonists and their application in therapy. Eur. Pat. Appl. EP 564, 356, 1993.
22. Weinstock, J.; Kennan, R. M.; Samanen, J.; Hempel, J.; Finkelstein, J. A.; Franz, R. G.; Gaitanopoulos, D. E.; Girard, G. R.; Gleason, J. G.; Hill, D. T.; Morgan, T. M.; Peishoff, C. E.; Aiyar, N.; Brooks, D. P.; Frederikson, T. A.; Ohlstein, E. H.; Ruffolo, R. R.;. Stack, E.J; Sulpizio, A. C.; Weidley, E. F.; Edwards, R. M. 1-(carboxybenzyl) imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists. J. Med. Chem. 1991, 34, 1514-1517.
23. Keenan, R. M.; Weinstock, J.; Finkelstein, J. A.; Frang, R. G.; Gaitanopoulos, D. E.; Girard, G. R.; Hill, D. J.; Morgan, T. M.; Samanen, J. M.; Pecshoff, C. E.; Tucker, L. M.; Aigar, N.; Griffin, E.; Ohlstein, E. M.; Stack, E. J.; Weidley, E. B.; Edwards, R. M. Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(carboxybenzyl) imidazole-5-acrylic acids. J. Med. Chem. 1993, 36, 1880-1892.
24. Greenlee, W. J. Hypertension - Treatment by blockade of the renin-angiotensin system. In Proceedings, XIVth International Symposium on Medicinal Chemistry; Awouters, F., Ed.; Elsevier Science: New York, 1997, pp 97-107.
25. Marie, J.; Seyer, R.; Lombard, C.; Desarnaud, F.; Aumelas, A.; Jard, S.; Bonnafous, J. C. Affinity chromatography purification of angiotensin II receptor using photoactivable biotinylated probes. Biochemistry 1990, 29, 8943-50.
26. 8 residue of angiotensin II. Unpublished results.
27. Thummel, R. C.; Föry, W. N-Azidophenylsulfonyl-N′-pyrimidinyl-and -triazinylureas. Eur. Pat. Appl. EP 102, 924, 1984.
28. Dickinson, R. P.; Barnish, I. T.; Cross, P. E. Brit. Pat. 1, 472, 843, 1977.
29. 3H]DuP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype. Biochem. Biophys. Res. Commun. 1990, 172, 1195-1202.
30. Dudley, D. T.; Panek, R. L.; Major, T. C.; Lu, G. H.; Bruns, R. F.; Klinkefus, B. A.; Hodges, J. C.; Weishaar, R. E. Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol. 1991, 38, 370-377.
31. Kitami, Y.; Okura, T.; Marumoto, K.; Wakamija, R.; Hiwada, K. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem. Biophys. Res. Commun. 1992, 188, 446-452.
32. Whitebread, S.; Mele, M.; Kamber, B.; de Gasparo, M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 1989, 163, 284-291.
33. Chiu, A. T.; Carini, D. J.; Duncia, J. V.; Leung, K. H.; McCall, D. E.; Price, W. A., Jr.; Wong, P. C.; Smith, R. D.; Wexler, R. R.; Timmermans, P. B. M. W. M.; Chang, R. S. L.; Lotti, V. J. DuP 532: a second generation of nonpeptide angiotensin II receptor antagonist. Biochem. Biophys. Res. Commun. 1991, 177, 209-217.
34. Parker, E. M.; Kamayama, K.; Hiyashijima, T.; E. M. Ross. Reconstitutively active G-protein-coupled receptors purified from baculovirus-infected insect cells. J. Biol. Chem. 1991, 266, 519-527.
35. 1 receptor for substance P and a non-peptide antagonist. Nature 1993, 362, 345-348.
36. Fong, T. M.; Huang, R. R. C.; Strader, C. D. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem. 1992, 267, 25664-25667.
37. Beinborn, M.; Lee, Y. M.; McBride, E. W.; Quinn, S. M.; Kopin, A. S. A single amino acid of the cholecystokinin-B gastrin receptor determines specificity for non-peptide antagonists. Nature 1993, 362, 348-350.
38. Fong, T. M.; Yu, H.; Strader, C. D. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96, 345 and RP 67580. J. Biol. Chem. 1992, 267, 25668-25671.
39. Elling, C. E.; Schwartz, T. W. Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering. EMBO J. 1996, 15, 6213-6219.
40. Schambye, H. T.; Hjorth, S. A.; Bergsma, D. J.; Sathe, G.; Schwartz, T. W. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. Proc. Natl. Acad. Sci. 1994, 91, 7046-7050.
41. 1 angiotensin receptor. J. Biol. Chem. 1994, 269, 16533-16536.
42. 1A angiotensin II receptor are involved in the differential recognition of peptide and nonpeptide ligands. Biochem. Biophys. Res. Commun. 1995, 209, 153-160.
43. Huang, R. R. C.; Yu, H.; Strader, C. D.; Fong, T. M. Localization of the ligand binding site of the neurokinin-1 receptor interpretation of chimeric mutations and single-residue substitutions. Mol. Pharmacol. 1994, 45, 690-695.
44. 1 angiotensin II receptor with a photoactivable radioactive nonpeptide antagonist. Can. J. Physiol. Pharmacol. 1994, 72, 554.
45. 2]azido-CP-96, 345, a photoreactive derivative of a nonpeptide antagonist. Mol. Pharmacol. 1996, 49, 808-813.
46. Farrens, D. L.; Altenbach, C.; Yang, K.; Hubbell, W. L.; Khorana, H. G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 1996, 274, 768-770.
47. Sheikh, S.; Zvyaga, T.; Lichtarge, O.; Sakmar, T.; Bourne, H. Rhodopsin activation blocked by metal-ion binding sites linking transmembrane helices C and F. Nature 1996, 383, 347-350.
48. 2 adrenoreceptor. EMBO J. 1997, 16, 6737-6747.
49. 2-adrenergic receptor alters the orientation of its sixth membrane-spanning segment. J. Biol. Chem. 1997, 272, 18546-18549.
50. 1A angiotensin II receptor induces its constitutive activation. J. Biol. Chem. 1997, 272, 1822-1826.
51. Kenakin, T. Receptor conformational induction versus selection: all part of the same energy landscape. Trends Pharmacol. Sci. 1996, 17, 190-191.
52. Schwartz, T. W.; Rosenkilde, M. M. Is there a "lock for all agonist "keys" in 7TM receptors? Trends Pharmacol. Sci. 1996, 17, 213-216.
53. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265.
54. Ekins, R. P.; Newman, G. B.; O'Riordan, J. L. H. Radioisotopes in Medicine: In vitro studies; Raymond, L. H., Goswitz, F. A., Murphy, B. E. P., Eds.; US: Oak Ridge, 1968; p 59.